SonoScape Medical Announces the Release of S-Fetus 4.0 to Simplify Sonography Process

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company’s flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening technology based on deep learning.

Leveraging the deep learning techniques, the S-Fetus 4.0 Obstetric Screening Assistant allows doctors to automatically acquire standard planes and measure fetal biometry with fast performance and accuracy. Without the need for manually repetitive operation of the device, the system was designed with one-click simple touch to streamline the sonogram pocess and improve scanning efficiency. “Our obstetric screening assistant has achieved breakthroughs in terms of performance and scalability and now it can offer more efficient means of smart obstetric diagnosis that assist doctors in precise work to ensure better patient outcomes”, said Zhou Guoyi, Head of SonoScape Medical Innovation Research Center.

To improve service capability, SonoScape applied this newly upgrade to a variety of high-end ultrasound equipment. The S-Fetus 4.0 is going to run on SonoScape S60, P60, P60 Exp, S50 Elite, P50 Elite and P40 Elite, both in the North America and ROW Region. “With our commitment to the independent R&D and innovation of medical equipment, our cutting edge technology has been able to realize its potential to serve medical institutions around the world”, commented Naizhang Feng, Vice President of SonoScape Ultrasound Division.

The S-Fetus 4.0 Obstetric Screening Assistant is powered by Intel® oneAPI Toolkits.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.